ESRRG and neoplasm: High m6A methylation level in drug-resistant cells can trigger the splicing of ESRRG precurser, increases the expression of CPT1B and induces up-regulation of ERRγ in chemoresistant cells, which can promote fatty acid oxidation of tumor cells and enhance chemoresistance of tumor cells [142].